Protagonist Stock 120%, Fund Outlook and Exit Signals
A hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
Explore annual tax harvesting for index funds to improve after-tax outcomes in retirement, with a straightforward plan you can adapt.
16,327 articlesA hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
A U.S. Senate probe questions Binance over Iran sanctions. The exchange says its compliance systems are robust, while...
Wall Street is backing tokenized real-world assets on Ethereum, cementing ETH as a core platform for on-chain finance...
Investors are hoarding cash as volatility climbs and policy signals shift risk expectations. The dash cash only just ...
REZ steadies its footing as a mix of healthcare REITs and self-storage assets cushions exposure to a softening reside...
May delivered a sharp reversal for Bitcoin ETFs, with the biggest weekly outflows since January as risk-off trading s...
As SpaceX eyes an IPO, investors wonder how Starlink's trajectory could change. This guide breaks down potential futu...
SpaceX’s impending IPO is driving the launch of leveraged ETFs designed to amplify bets on the rocket company, offeri...
Savers face a rate tug-of-war in 2026 as money market accounts high yields compete with high yield savings accounts. ...
Investors are racing to price in the first real revenue opportunities from quantum tech as a new federal funding push...
BonkDAO’s governance proposal drained roughly $20 million in BONK from its treasury, underscoring a new risk surface ...
A Palestinian activist has filed a federal lawsuit accusing a network of conservative groups of coordinating to silen...